AU2001253469A1 - Compositions and methods for stabilizing modified tissue - Google Patents

Compositions and methods for stabilizing modified tissue

Info

Publication number
AU2001253469A1
AU2001253469A1 AU2001253469A AU5346901A AU2001253469A1 AU 2001253469 A1 AU2001253469 A1 AU 2001253469A1 AU 2001253469 A AU2001253469 A AU 2001253469A AU 5346901 A AU5346901 A AU 5346901A AU 2001253469 A1 AU2001253469 A1 AU 2001253469A1
Authority
AU
Australia
Prior art keywords
compositions
methods
modified tissue
stabilizing
stabilizing modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253469A
Inventor
Ali Zendedel Haghighi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUNRISE TECHNOLOGIES INTERNATIONAL Inc
Original Assignee
SUNRISE TECHNOLOGIES INTERNATI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUNRISE TECHNOLOGIES INTERNATI filed Critical SUNRISE TECHNOLOGIES INTERNATI
Publication of AU2001253469A1 publication Critical patent/AU2001253469A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
AU2001253469A 2000-04-27 2001-04-13 Compositions and methods for stabilizing modified tissue Abandoned AU2001253469A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55993300A 2000-04-27 2000-04-27
US09559933 2000-04-27
US09/559,933 2000-04-27
PCT/US2001/012127 WO2001082933A2 (en) 2000-04-27 2001-04-13 Compositions and methods for stabilizing modified tissue

Publications (1)

Publication Number Publication Date
AU2001253469A1 true AU2001253469A1 (en) 2001-11-12

Family

ID=24235662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253469A Abandoned AU2001253469A1 (en) 2000-04-27 2001-04-13 Compositions and methods for stabilizing modified tissue

Country Status (2)

Country Link
AU (1) AU2001253469A1 (en)
WO (1) WO2001082933A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
WO2013148896A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Ocular treatment solutions, delivery devices and delivery augmentation methods
US9555111B2 (en) 2012-03-29 2017-01-31 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
WO2013149075A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2948708B2 (en) * 1991-11-27 1999-09-13 ニューヨーク・ブラッド・センター・インコーポレーテッド Fibronectin-containing eye drops
WO1993015234A1 (en) * 1992-01-22 1993-08-05 Novo Nordisk A/S Activated factor xiii
AU675304B2 (en) * 1993-06-04 1997-01-30 Senju Pharmaceutical Co., Ltd. Ophthalmic topical agent

Also Published As

Publication number Publication date
WO2001082933A2 (en) 2001-11-08
WO2001082933A3 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
AU2001249967A1 (en) Composition and methods for tissue preservation
AU2001286704A1 (en) Surgical stabilizer devices and methods
EP1157707B8 (en) Method and composition for deforming soft tissues
AU2778801A (en) Antisense compositions and methods
AU2001251136A1 (en) Compositions and methods for promoting wound healing
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU2001233081A1 (en) Composition for treatment of stress
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
AU2002213114A1 (en) Compositions and methods for reducing gnrh-induced bone loss
AU2001259702A1 (en) Tissue regrafting
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
WO2001091700A8 (en) Composition and method for enhancing elasticity of tissue
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002353078A1 (en) Tissue graft compositions and methods for producing same
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2002245510A1 (en) Method and composition for embalming
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem